Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?

BACKGROUND: The primary objective of this study was to report the incidence of bloodstream infections (BSIs) and clinically or microbiologically proven bacterial or fungal BSIs during neutropenic episodes in patients with hematological malignancies. METHODS: In this retrospective observational study...

Descripción completa

Detalles Bibliográficos
Autores principales: Gedik, Habip, Şimşek, Funda, Kantürk, Arzu, Yildirmak, Taner, Arica, Deniz, Aydin, Demet, Demirel, Naciye, Yokuş, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172031/
https://www.ncbi.nlm.nih.gov/pubmed/25258539
http://dx.doi.org/10.2147/TCRM.S68450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172031/
https://www.ncbi.nlm.nih.gov/pubmed/25258539
http://dx.doi.org/10.2147/TCRM.S68450

Ejemplares similares